| Market Cap | ₹70Cr |
| ROE | 9.35% |
| P/E Ratio(TTM) | 8.29 |
| EPS(TTM) | 3.96 |
| P/B Ratio | 0.78 |
| Dividend Yield | 0.00% |
| Industry P/E | 34.72 |
| Book Value | 41.90 |
| Debt to Equity | 0.69 |
| Face Value | 10 |
| Parent Organisation | Vivo Bio Tech Limited |
| Managing Director | NA |
| BSE Symbol | 511509 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Biocon | NA (0.00%) | 78.41 | ||
| Anthem Biosciences | NA (0.00%) | 86.62 | ||
| Onesource Specialty Pharma | NA (0.00%) | -1622.73 | ||
| Advanced Enzyme Technologies | NA (0.00%) | 25.00 |